| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029586 |
| Receipt No. | R000033779 |
| Official scientific title of the study | The opportune time for periarticular injection during total hip arthroplasty under general anesthesia: a randomized controlled trial |
| Date of disclosure of the study information | 2017/10/17 |
| Last modified on | 2018/06/19 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | The opportune time for periarticular injection during total hip arthroplasty under general anesthesia: a randomized controlled trial | |
| Title of the study (Brief title) | The opportune time for periarticular injection during total hip arthroplasty under general anesthesia: a randomized controlled trial | |
| Region |
|
|
| Condition | ||
| Condition | Osteoarthritis of the hip, rheumatoid arthritis, avascular necrosis of the femoral head, Femoral neck fracture | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to compare the efficacy of periarticular injection between inject after the implantation of prosthesis and inject just prior to the arthrotomy in total hip arthroplasty under general anesthesia |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Pain score (Visual analogue scale) at recovery room |
| Key secondary outcomes | Pain score (Visual analogue scale) 3, 6, 9, 12, 24 and 48 hours after surgery
Blood loss Complications The consumption of remifentanil The use of naloxone |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | NO |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Periarticular injection prior to the arthrotomy and nomal saline injection after the implantation of prosthesis. | |
| Interventions/Control_2 | Nomal saline injection prior to the arthrotomy and periarticular injection injection after the implantation of prosthesis. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients scheduled for unilateral total hip arthroplasty | |||
| Key exclusion criteria | Patients scheduled for simultaneous bilateral total hip arthroplasty.
Patients scheduled for revision total hip arthroplasty. Patients scheduled for total hip arthroplasty with shortening subtrochanteric osteotomy. Patients who had allergy or intolerance to one of the study drugs, regular narcotic use, renal insufficiency and prolonged QT interval on ECG. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Kenji Kurosaka |
| Organization | Hokusuikai Kinen Hospital |
| Division name | Orthopaedic surgery |
| Address | 3-2-1 Higashihara, Mito, Ibaraki, 310-0035 Japan |
| TEL | 029-303-3003 |
| kenjikurosaka@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Kenji Kurosaka |
| Organization | Hokusuikai Kinen Hospital |
| Division name | Orthopaedic surgery |
| Address | 3-2-1 Higashihara, Mito, Ibaraki, 310-0035 Japan |
| TEL | 029-303-3003 |
| Homepage URL | |
| kenjikurosaka@yahoo.co.jp | |
| Sponsor | |
| Institute | Hokusuikai Kinen Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hokusuikai Kinen Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033779 |